Table 1.
Antibody | Index | ΔΔGbind | EαPα | EβPβ | −ErsaPrsa | Eeff |
---|---|---|---|---|---|---|
47e | Y100a | −1.51 | 0 | 0 | −2.94 | −19.05 |
Y100g | 24.54 | 0 | 0 | −2.61 | 7.33 | |
Y100h | 22.21 | 0 | 0 | −2.39 | 5.22 | |
412d | Y96 | 31.60 | 0 | 10.99 | −1.76 | 26.23 |
Y100 | 25.59 | 0 | 0 | −2.83 | 8.16 | |
Y100c | 7.03 | 0 | 0 | −3.01 | −10.58 | |
Y100l | 28.62 | 0 | 2.75 | −1.65 | 15.12 |
Note: The unit is kcal/mol. The contributions of secondary structure unfolding and solvent exposure are also shown. The sequence of the variable loop, CDR3, in the antibody 47e is GGEDGDYLSDPFYYNHGMDVW, where the examined tyrosines are 100a, 100 g and 100 h, shown in boldface and underlined. The CDR3 sequence of the antibody 412d is YCASPYPNDYNDYAPEEGMSWYFDL, where the examined tyrosines are 96, 100, 100C and 100L. The experimentally validated tyrosines that undergo sulfation are highlighted using boldface font.